公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2016 | Daclatasvir plus asunaprevir for HCV genotype 1b infection in patients with or without compensated cirrhosis: a pooled analysis | JIA-HORNG KAO ; Jensen D.M.; Manns M.P.; Jacobson I.; Kumada H.; Toyota J.; Heo J.; Yoffe B.; Sievert W.; Bessone F.; Peng C.-Y.; Roberts S.K.; Lee Y.-J.; Bhore R.; Mendez P.; Hughes E.; Noviello S. | Liver International | 12 | 11 | |
2016 | Daclatasvir-containing all-oral regimens for the treatment of hepatitis C virus infection | Yang S.-S.; JIA-HORNG KAO | Hepatology International | 8 | 8 | |
2017 | Daclatasvir/asunaprevir/beclabuvir, all-oral, fixed-dose combination for patients with chronic hepatitis C virus genotype 1 | JIA-HORNG KAO ; Yu M.-L.; Peng C.-Y.; Heo J.; Chu C.-J.; Chang T.-T.; Lee Y.-J.; Hu T.-H.; Yoon K.T.; Paik S.W.; Lim Y.S.; Ahn S.H.; Isakov V.; McPhee F.; Hu W.; Scott Swenson E.; Yin P.D.; Treitel M. | Journal of Gastroenterology and Hepatology (Australia) | 17 | 12 | |
1994 | Detection of divergent hepatitis C virus envelope sequences | JIA-HORNG KAO ; PEI-JER CHEN ; Lai M.-Y.; PEI-MING YANG ; JIN-CHUAN SHEU ; Wang T.-H.; DING-SHINN CHEN | Journal of Biomedical Science | 4 | 0 | |
2012 | Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral load | TAI-CHUNG TSENG ; CHUN-JEN LIU ; HUNG-CHIH YANG ; TUNG-HUNG SU ; Wang C.-C; CHI-LING CHEN ; Fang-Tzu Kuo S; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Hepatology | 129 | 115 | |
2023 | Development of hepatocellular carcinoma in treated and untreated patients with chronic hepatitis B virus infection | Lin, Chih-Lin; JIA-HORNG KAO | Clinical and molecular hepatology | 6 | 2 | |
2008 | Diagnosis of hepatitis B virus infection through serological and virological markers | JIA-HORNG KAO | Expert Review of Gastroenterology and Hepatology | 106 | 0 | |
2012 | Differential clinical and virologic impact of hepatitis B virus genotypes B and C on HIV-coinfected patients receiving lamivudine-containing highly active antiretroviral therapy | WANG-HUEI SHENG ; CHIEN-CHING HUNG ; SUI-YUAN CHANG ; CHUN-JEN LIU ; Chen M.-Y.; SZU-MIN HSIEH ; JIA-HORNG KAO ; PEI-JER CHEN ; SHAN-CHWEN CHANG | Clinical Infectious Diseases | 13 | 12 | |
2010 | Differential effects of interferon and lamivudine on serum HBV RNA inhibition in patients with chronic hepatitis B | Huang Y.-W.; Chayama K.; Tsuge M.; Takahashi S.; Hatakeyama T.; Abe H.; Hu J.-T.; CHUN-JEN LIU ; Lai M.-Y.; DING-SHINN CHEN ; Yang S.-S.; JIA-HORNG KAO | Antiviral Therapy | 39 | 38 | |
2023 | Differential Relapse Patterns After Discontinuation of Entecavir vs Tenofovir Disoproxil Fumarate in Chronic Hepatitis B | Choi, Hannah S J; Hirode, Grishma; Chen, Chien-Hung; TUNG-HUNG SU ; Seto, Wai-Kay; Van Hees, Stijn; Papatheodoridi, Margarita; Lens, Sabela; Wong, Grace L H; Brakenhoff, Sylvia M; Chien, Rong-Nan; Feld, Jordan J; Sonneveld, Milan J; Chan, Henry L Y; Forns, Xavier; Papatheodoridis, George V; Vanwolleghem, Thomas; Yuen, Man-Fung; Hsu, Yao-Chun; JIA-HORNG KAO ; Cornberg, Markus; Hansen, Bettina E; Jeng, Wen-Juei; Janssen, Harry L A | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 9 | | |
2021 | Direct comparison of biopsy techniques for hepatic malignancies | SHANG-CHIN HUANG ; JA-DER LIANG ; SHIH-JER HSU ; TZU-CHAN HONG ; HUNG-CHIH YANG ; JIA-HORNG KAO | Clinical and molecular hepatology | 12 | 9 | |
2024 | Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions | Marshall, Alison D; Willing, Alex R; Kairouz, Abe; Cunningham, Evan B; Wheeler, Alice; O'Brien, Nicholas; Perera, Vidura; Ward, John W; Hiebert, Lindsey; Degenhardt, Louisa; Hajarizadeh, Behzad; Colledge, Samantha; Hickman, Matthew; Jawad, Danielle; Lazarus, Jeffrey V; Matthews, Gail V; Scheibe, Andrew; Vickerman, Peter; Dore, Gregory J; Grebely, Jason; JIA-HORNG KAO et al. | The lancet. Gastroenterology & hepatology | 2 | | |
2019 | Direct-acting antivirals in East Asian hepatitis C patients: real-world experience from the REAL-C Consortium | Huang C.-F.; Iio E.; Jun D.W.; Ogawa E.; Toyoda H.; Hsu Y.-C.; Haga H.; Iwane S.; Enomoto M.; Lee D.H.; Wong G.; CHEN-HUA LIU ; Tada T.; Chuang W.-L.; Cheung R.; Hayashi J.; Tseng C.-H.; Yasuda S.; Tran S.; Kam L.; Henry L.; Jeong J.Y.; Nomura H.; Park S.H.; Nakamuta M.; Huang J.-F.; Tai C.-M.; Lo G.-H.; Lee M.-H.; Yang H.-I.; JIA-HORNG KAO ; Tamori A.; Eguchi Y.; Ueno Y.; Furusyo N.; Tanaka Y.; Yu M.-L.; Nguyen M.H.; For the REAL-C Investigators | Hepatology International | 31 | 27 | |
2006 | Discontinuation of lamivudine treatment for hepatitis flare after kidney or heart transplantation in hepatitis B surface antigen-positive patients: A retrospective case series | Huang Y.-W.; CHUN-JEN LIU ; Lai M.-Y.; PO-HUANG LEE ; MENG-KUN TSAI ; SHOEI-SHEN WANG ; Lai M.-K.; JIA-HORNG KAO | Clinical Therapeutics | 7 | 6 | |
2008 | Disease progression in a patient with nonalcoholic steatohepatitis | PING-HUEI TSENG ; CHUN-JEN LIU ; JIA-HORNG KAO ; CHIA-TUNG SHUN ; PEI-JER CHEN ; DING-SHINN CHEN | Journal of the Formosan Medical Association | 10 | 6 | |
2023 | Distinct effects of hepatic steatosis and metabolic dysfunction on the risk of hepatocellular carcinoma in chronic hepatitis B | SHANG-CHIN HUANG ; TUNG-HUNG SU ; TAI-CHUNG TSENG ; CHI-LING CHEN ; SHIH-JER HSU ; SIH-HAN LIAO ; CHUN-MING HONG ; CHEN-HUA LIU ; Lan, Ting-Yuan; HUNG-CHIH YANG ; CHUN-JEN LIU ; PEI-JER CHEN ; JIA-HORNG KAO | Hepatology international | 5 | 2 | |
2013 | Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversion | HUNG-CHIH YANG ; CHI-LING CHEN ; Shen Y.-C; Peng C.-Y; CHUN-JEN LIU ; TAI-CHUNG TSENG ; TUNG-HUNG SU ; Chuang W.-L; Yu M.-L; Dai C.-Y; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Hepatology | 43 | 37 | |
2018 | Distinct Relapse Rates and Risk Predictors after Discontinuing Tenofovir and Entecavir Therapy | TUNG-HUNG SU ; HUNG-CHIH YANG ; TAI-CHUNG TSENG ; JYH-MING LIOU ; CHEN-HUA LIU ; CHI-LING CHEN ; PEI-JER CHEN ; DING-SHINN CHEN ; CHUN-JEN LIU ; JIA-HORNG KAO | Journal of Infectious Diseases | 57 | 52 | |
2023 | Diversity and composition of gut microbiota in healthy individuals and patients at different stages of hepatitis B virus-related liver disease | Lin, Meng-Ju; TUNG-HUNG SU ; CHIEH-CHANG CHEN ; WEI-KAI WU ; SHIH-JER HSU ; TAI-CHUNG TSENG ; SIH-HAN LIAO ; CHUN-MING HONG ; HUNG-CHIH YANG ; CHUN-JEN LIU ; MING-SHIANG WU ; JIA-HORNG KAO | Gut pathogens | 2 | 2 | |
2021 | Drug Resistance Profile and Clinical Features for Hepatitis C Patients Experiencing DAA Failure in Taiwan | CHUN-MING HONG ; Lin, You-Yu; CHUN-JEN LIU ; Lai, Ya-Yun; Shiou-Hwei Yeh ; HUNG-CHIH YANG ; JIA-HORNG KAO ; SHIH-JER HSU ; Huang, Yi-Hsiang; Yang, Sheng-Shun; Kuo, Hsing-Tao; Cheng, Pin-Nan; Yu, Ming-Lung; PEI-JER CHEN | Viruses | 5 | 2 | |